Prempro

Manson and others who worked on the WHI study noted the women in it were on average 63 — a decade past menopause.

They wondered what would happen with younger women, just entering menopause.

So they used data from the Nurses' Health Study, an ongoing study of 121,700 female nurses, age 30 to 55 when it started in 1976.

Every two years these women have filled out detailed questionnaires on their health, habits and medications.

When they died, their medical records were carefully added.

Continued 1.   2.   NEXT» Print This StoryPrint This Story E-mail This ArticleEmail This Article RSS Headlines Newsletters Bush Calls Wiretapping a Vital Part of War on Terror West Virginia Governor Vows to Make Mines 'Safest in the World' Vow for Mine Safety Most Sent Headlines Nursing Shortage: How it May Affect YouSchools, Parents Cracking Down on Web SocializingCreepy and Crawly: Bedbugs Invade U.S.

ABC News Home Contact ABC News .

ABC.com .

Help & Info .

Advertising Info .

Terms of Use .

Privacy Policy/Your California Privacy Rights Copyright © 2006 ABC News Internet Ventures ...

Manson and others who worked on the WHI study noted the women in it were on average 63 - a decade past menopause.

They wondered what would happen with younger women, just entering menopause.

So they used data from the Nurses' Health Study, an ongoing study of 121,700 female nurses, age 30 to 55 when it started in 1976.

Every two years these women have filled out detailed questionnaires on their health, habits and medications.

When they died, their medical records were carefully added.

30 PERCENT LOWER RISK The nurses' data showed that if women took HRT at younger ages, they had a 30 percent lower risk of heart disease than women the same age who did not take HRT.

"It does suggest that women who are good candidates for hormone therapy because they are recently menopausal and having moderate to severe hot flashes and are at low risk of heart disease may not need to be alarmed about the (earlier) findings," Manson said in a telephone interview.

"The evidence is beginning to converge.

But it is certainly not conclusive.

We don't want people running out and taking hormone therapy and thinking it was going to protect their heart and that there are no risks involved." Writing in the Journ...

TechniTab, Inc.

develops products that enhance their customers' quality of life.

Technitab, Inc.

provides outstanding and innovative products of the finest quality and value that are safe, cost-effective and easy to use.

DemiDose(TM) is a trademark of PDTT TechniTab, Inc.

All other trademarks are the property of their respective owners.

* Average savings off retail prices for medications listed SOURCE TechniTab, Inc.

Web Site: http://www.split12.com Photo Notes: NewsCom: http://www.newscom.com/cgi-bin/prnh/20060111/NYW110 AP Archive: http://photoarchive.ap.org PRN Photo Desk,photodesk@prnewswire.com Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.Terms and conditions, including restrictions on redistribution, apply.

Copyright © 1996- PR Newswire Association LLC.

All Rights Reserved.

A United Business Media company.

...